Related Experiment Video
Updated: Jun 19, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Global mortality associated with rotavirus disease among children in 2004
Umesh D Parashar1, Anthony Burton, Claudio Lanata
1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. uap2@cdc.gov
Insights
Rotavirus infection causes over 500,000 deaths annually in children under 5, highlighting the need for effective rotavirus vaccines. Targeted vaccination strategies are crucial for reducing child mortality globally.
Area of Science:
- Global Health
- Infectious Diseases
- Vaccinology
Background:
- Estimating rotavirus disease burden is essential for assessing vaccine benefits and impact.
- New rotavirus vaccines necessitate updated global and national mortality data.
Purpose of the Study:
- To estimate global rotavirus-associated mortality in children under 5 years old.
- To provide baseline data for monitoring rotavirus vaccine impact.
Main Methods:
- Systematic review of 76 studies initiated after 1990 on rotavirus in hospitalized children.
- Categorization of studies into 5 groups based on child mortality and geography.
- Calculation of rotavirus-associated mortality by multiplying detection rates with diarrhea mortality data.
Main Results:
- Rotavirus caused an estimated 527,000 deaths annually in children under 5, representing 29% of all diarrhea-related deaths.
- India accounted for 23% of rotavirus deaths; 6 countries bore over half of the global burden.
- Significant rotavirus mortality was observed in India, Nigeria, Congo, Ethiopia, China, and Pakistan.
Conclusions:
- High rotavirus mortality necessitates targeted interventions, particularly vaccines.
- Ensuring vaccine access in high-mortality countries is vital for maximizing impact.
- Established baseline mortality figures will enable future assessments of vaccine effectiveness.
Background:
As new rotavirus vaccines are being introduced in immunization programs, global and national estimates of disease burden, especially rotavirus-associated mortality, are needed to assess the potential health benefits of vaccination and to monitor vaccine impact.
Methods:
We identified 76 studies that were initiated after 1990, lasted at least 1 full year, and examined rotavirus among >100 children hospitalized with diarrhea. The studies were assigned to 5 groups (A-E) with use of World Health Organization classification of countries by child mortality and geography. For each group, the mean rotavirus detection rate was multiplied by diarrhea-related mortality figures from 2004 for countries in that group to yield estimates of rotavirus-associated mortality.
Results:
Overall, rotavirus accounted for 527,000 deaths (95% confidence interval, 475,000-580,000 deaths) annually or 29% of all deaths due to diarrhea among children <5 years of age. Twenty-three percent of deaths due to rotavirus disease occurred in India, and 6 countries (India, Nigeria, Congo, Ethiopia, China, and Pakistan) accounted for more than one-half of deaths due to rotavirus disease.
Conclusions:
The high mortality associated with rotavirus disease underscores the need for targeted interventions, such as vaccines. To realize the full life-saving potential of vaccines, it will be vital to ensure that they reach children in countries with high mortality. These baseline figures will allow future assessment of vaccine impact on rotavirus-associated mortality.
Related Concept Videos
Cholera
Poliomyelitis
Respiratory Syncytial Virus Disease
Bacterial Gastroenteritis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease
